Literature DB >> 12620637

Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved?

Robert H Swanborg1, Judith A Whittum-Hudson, Alan P Hudson.   

Abstract

A good deal of evidence suggests an infectious component in the development of multiple sclerosis (MS) and, to date, some 20 bacteria and viruses have been associated with the disease. Recent independent sets of studies have implicated the respiratory bacterium Chlamydia pneumoniae and human herpes virus 6 (HHV-6) in the pathogenesis of MS. However, as is the case for essentially all earlier microbial associations, experimental evidence linking either this bacterium or this virus to MS is equivocal. We review the published reports concerning involvement of C. pneumoniae and HHV-6 in MS, and data relating to possession of the APOE epsilon 4 allele, which some studies indicate might influence how these or other pathogens affect disease genesis. Based on the large set of inconsistent observations available and given important new information regarding the neuropathology of MS, we contend that no conclusion is possible at this point regarding the potential role of either C. pneumoniae or HHV-6 in MS. We therefore propose future studies that should clarify whether, and if so how, these and other organisms function in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620637     DOI: 10.1016/s0165-5728(02)00465-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

Review 1.  Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?

Authors:  Kensuke Shima; Gregor Kuhlenbäumer; Jan Rupp
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

2.  Plasmacytoid dendritic cells in multiple sclerosis: chemokine and chemokine receptor modulation by interferon-beta.

Authors:  Latt Latt Aung; Patricia Fitzgerald-Bocarsly; Suhayl Dhib-Jalbut; Konstantin Balashov
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

3.  Multiple sclerosis in stepsiblings: recurrence risk and ascertainment.

Authors:  D A Dyment; I M L Yee; G C Ebers; A D Sadovnick
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-02       Impact factor: 10.154

Review 4.  Etiology and pathogenesis of late-onset Alzheimer's disease.

Authors:  Brian J Balin; Alan P Hudson
Journal:  Curr Allergy Asthma Rep       Date:  2014-03       Impact factor: 4.806

Review 5.  Microglial Phenotypes and Functions in Multiple Sclerosis.

Authors:  Elaine O'Loughlin; Charlotte Madore; Hans Lassmann; Oleg Butovsky
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

6.  Disease modifying agents for multiple sclerosis.

Authors:  Olga Hilas; Priti N Patel; Sum Lam
Journal:  Open Neurol J       Date:  2010-05-26

Review 7.  Update on immunopathogenesis and immunotherapy in multiple sclerosis.

Authors:  Rebecca C Selter; Bernhard Hemmer
Journal:  Immunotargets Ther       Date:  2013-04-25

8.  Cerebrospinal Fluid in a Small Cohort of Patients with Multiple Sclerosis Was Generally Free of Microbial DNA.

Authors:  Juan Jovel; Sandra O'keefe; Jordan Patterson; Michael Bording-Jorgensen; Weiwei Wang; Andrew L Mason; Kenneth G Warren; Gane Ka-Shu Wong
Journal:  Front Cell Infect Microbiol       Date:  2017-01-06       Impact factor: 5.293

Review 9.  Amplification of autoimmune disease by infection.

Authors:  David N Posnett; Dmitry Yarilin
Journal:  Arthritis Res Ther       Date:  2005-02-10       Impact factor: 5.156

10.  The effect of cellular differentiation on HSV-1 infection of oligodendrocytic cells.

Authors:  Raquel Bello-Morales; Antonio Jesús Crespillo; Beatriz García; Luis Ángel Dorado; Beatriz Martín; Enrique Tabarés; Claude Krummenacher; Fernando de Castro; José Antonio López-Guerrero
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.